Leading provider of advanced EDC solutions for managing clinical trial data offers customers the market’s best clinical trial technologies integrated into a single platform
Boston, Mass.– August 10, 2009 – KIKA Clinical Solutions, the leading provider of advanced EDC solutionsfor clinical trials, announced the KIKA Partners Program to proliferate the continued widespread adoption of its Clinical Asset Management™ solutions in the pharma, biotech and medical device industries.
The KIKA Partner Program enables KIKA customers to use best-in-breed technologies and services, all integrated into KIKA’s platform. Zaher El-Assi, KIKA Senior Director of Global Sales and Strategic Partnerships, explained, “The KIKA Partner Program provides our customers with a full clinical suite that integrates the top clinical trial technologies into a single platform. Customers no longer have to use one vendor with products of varying quality, or multiple solutions from different vendors.” Current KIKA partners provide technologies including randomization, coding, CTMS and ePRO.
KIKA’s unique Web services architecture enables the Company to integrate its Clinical Asset Management™solution with partners’ offerings very easily.
There are three types of KIKA partnerships:
1. Technology and Service – Partners provide services or technologies that augment KIKA’s EDC offering. They can use KIKA technology to enhance their own product products as well. This enables integration of the best capabilities into one offering platform
2. CROs (Contract Research Organizations) – KIKA offers three opportunities for CROs: Software as a Service (SaaS), a partial technology transfer, or a full technology transfer.
3. Co-Marketing – Partners who have knowledge of trials where KIKA’s solution is a good fit for a trial are referred to KIKA. The same holds true for KIKA’s awareness of trials that may be able to use a partner’s technology or service. Both sales teams are trained on the respective offering, expanding the marketing effort.
Mr. El-Assi said, “These are real partnerships with active relationships and measurable goals. Every partnership begins with developing a comprehensive understanding of each company’s product and services. We then develop an operational plan to provide maximum sales and revenue benefit for each party.” Mr. El-Assi added that KIKA and partners are engaged in discussing opportunities for joint product development.
Additional advantages of the KIKA Partner Program include mutual attendance at sales meetings; co-marketing such as news releases and joint industry event participation; and advertising opportunities.
To learn more about the benefits of the KIKA Partner Program contact Zaher El-Assi at 617-953-4776 or email zelassi@kikamedical.com.
KIKA Clinical Solutions
KIKA helps the world's most innovative biopharmaceutical and medical device organizations bring much-needed medical solutions to the market faster. KIKA’s Clinical Asset Management™ platform provides unmatched flexibility and customization with advanced EDC including images and online adjudication. For more information, visit www.kikaclinicalsolutions.com.
KIKA, Veracity and Clinical Asset Management are trademarks of the KIKA group of companies.
Media contact: Brenda Nashawaty, bnashawaty@kikamedical.com, 617-688-3253